We have previously shown that rat brain tubulin, a heterodimer consisting of an a and fi monomer, can be covalently labeled with [3H]colchicine by near UV irradiation. Most of the label appears in (&tubulin. We show here that (3-tubulin can be separated and purified from SDS preparative gels and analyzed by proteolysis. Chymotrypsin yielded a labeled -4-kDa band that contained two peptides. Tryptic digestion also yielded an =4-kDa band containing two peptides. Sequence analysis revealed a peptide ofresidues 1-36 and 213-242 for chymotrypsin and a peptide of residues 1-46 and 214-241 for trypsin. To identify which peptide carried the label, limited hydrolysis of -tubulin was done with trypsin; this procedure yielded a labeled 16-kDa N-terminal peptide and a 35-kDa C-terminal peptide, as identified by antibodies. Isolation of these peptides and extensive digestion with trypsin yielded two labeled peptides corresponding to residues 1-46 from the 16-kDa N-terminal fragment and residues 214-241 from the 35-kDa C-terminal fragment. These results show that at least two regions in P-tubulin are specifically involved in colchicine binding and that the span of the colchicine molecule, s11 A, bridges these two regions in the native /3 monomer.
Colchicine is the most studied of all antimitotic agents. It binds to tubulin with a stoichiometry of one and inhibits microtubule assembly substoichiometrically. Colchicine binding to tubulin exhibits pseudoirreversible kinetics; it displays a fast step followed by a slow step involving conformational changes of both ligand and tubulin. The latter, in turn, promote fluorescence characteristic of the tropolone moiety of colchicine. Many analogs have been studied, resulting in the proposal that the A and C rings of colchicine both bind to specific loci, whereas the B ring is primarily a regulator of binding kinetics (see refs. 1 and 2 and the references therein).
Attempts to localize the binding site(s) in the tubulin dimer have led to conflicting results. Studies with bromacetylcolchicine indicated binding to a-tubulin (3), but these results have been criticized on the basis of the nonspecificity of the alkylation reaction. Proteolytic studies of the colchicinetubulin complex yielded a-tubulin-derived, colchicinebearing peptides of [16] [17] [18] kDa; because z90% of the label bound to the protein was lost during processing, conclusions are uncertain (4) . Others (5) have also shown colchicine localization to a-tubulin by using a photoaffinity label with a long spacer arm. A shorter spacer arm led to colchicine binding on both a-and ,B-tubulins (6) , suggesting that localization was a function ofthe spacer length. On the other hand, Luduena and Roach (7) have shown, on the basis of blocking sulfhydryl-group crosslinking, that the 13 monomer contained the colchicine-binding site. In a different approach, several groups have shown that many nontransport mutations associated with colchicine resistance occurred on -tubulin. However, mutations leading to colchicine resistance need not necessarily reside in the binding site(s). For 
example, low-
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ering the critical concentration for polymerization might promote such resistance (8) .
Finally, we have shown by direct photolabeling (at >325 nm) with unmodified [3H] colchicine that the label is localized almost exclusively on 3-tubulin. In late stages of irradiation, or with "damaged" tubulin, label also appeared in a-tubulin (9) . These results suggested the possibility that the colchicine-binding domain on 3-tubulin might be near a-tubulin. That proposal was strengthened by the finding that colchicine photosensitized the formation of covalent tubulin dimers, trimers, and tetramers when the colchicine-tubulin complex was irradiated (10) . Predominant labeling of (3-tubulin has also been demonstrated with chloroacetates of 2-or 3-demethylthiocolchicines (11) . Although covalent photolabeling of tubulin with [3H]colchicine is inefficient because of the photodegradation to lumicolchicine, the considerable specificity of this reaction for ,B3tubulin has allowed isolation of this monomer with sufficient label to permit further localization of the binding domain(s) from labeled peptides. We now report that colchicine can react with two regions of ,3-tubulin that are not close together in the amino acid sequence. These regions must be close to each other in the native structure of tubulin and comprise part of the site to which colchicine binds. (14) or 10-20% gradient tricine gels (Novex), and analyzed for radioactivity. The remaining portions of the gels were transferred to Immobilon-P membranes, stained for 1 min with 0.5% Ponceau-S in 1% acetic acid, destained with water, and dried. Bands were cut out and sequenced on an Applied Biosystems model 470 or 477 sequencer.
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We had previously shown (9) that the efficiency of tubulin labeling with [3H]colchicine by direct photolabeling was low because of the dominant photodegradation of colchicine to lumicolchicine. Nevertheless, by using mole ratios of 5-10 for colchicine/tubulin during incubation and irradiation, we could label 15-25% of the tubulin molecules without causing excessive radiation damage or tubulin oligomer formation (Fig. 1, lane 1) . Under these conditions .75% of the labeled colchicine was on j-tubulin.
Limited proteolysis by chymotrypsin of unirradiated and irradiated tubulin dimer yielded similar peptide patterns (Fig.  1, lanes 3 and 4, respectively) . There were, however, several additional fragments in the irradiated sample. These additional fragments may result from the presence of colchicine or from an effect of irradiation. Because the main interest was in identifying domains of P-tubulin and because a number of peptides would not be easily identified by antibodies as belonging to f3-tubulin, it seemed preferable to use the isolated f-tubulin.
Bulk separation of the a and a monomers in 3-or 5-mmthick SDS/8% polyacrylamide gels yielded -80% of the protein expected for each monomer, including losses from removal of the inter-a/a8 zone and losses from electroelution.
Compared with limited proteolysis of native tubulin with chymotrypsin, the isolated P-tubulin did not yield the expected cleavage (16) , and it became essential to remove the (concentrated) SDS from the ,-tubulin, as described in Materials and Methods. After this procedure the overall recovery was -40% of the protein or radioactivity of the starting material (Fig. 1, lanes 1 and 2) . Specific activities of .1000 dpm of 3H per ,g of protein were routinely obtained. results are quantified for 3H in Fig. 2C . Gel slice 7 was chosen for analysis after transfer to an Immobilon-P membrane. Sequence analysis revealed that this band was a mixture of two peptides. The first was from the extreme N-terminal portion of the monomer, yielding j-tubulin sequence 1-20 as follows: Met-Arg-Glu-Ile-Val-His-Ile-Gln-Ala-Gly-Gln-XaaGly-Asn-Gln-Ile-Gly-Ala-Xaa-Phe. The next tryptic cleavage site would be Arg-46, and the Lys-19 site was apparently not hydrolyzed during proteolysis.
The second peptide yielded the following partial sequence: Thr-Leu-Lys-Leu-Thr-Thr-Pro-Thr-Tyr-Gly. This sequence corresponds to /3tubulin residues 214-223 and suggests that the whole peptide extends to Arg-241, the next trypsin cleavage site in the sequence.
It is of interest to note that extensive chymotryptic hydrolysis of labeled ,-tubulin (Fig. 2B, lane 3) produced a labeled =3.8-kDa band that again proved to be a mixture of two peptides. These were roughly coextensive with the two tryptic peptides discussed above. Sequence analysis revealed that again one of the two peptides was from the extreme N terminus, yielding the partial sequence Met-Arg-Glu-Ile-ValHis-Ile-Gln-Ala (residues 1-9), which, extended to the next chymotrypsin cleavage site, would represent residues 1-20 or 1-36, the latter in better agreement with the apparent mass on SDS gels. The second peptide yielded the sequence Lys-LeuThr-Thr-Pro-Thr-Tyr-Gly-Asp-Leu-Asn-(-)Xaa-Leu-Val, coinciding with residues 216-229 of ,B-tubulin. The chymotryptic site at Tyr-222 was not hydrolyzed in the several determinations made. The next chymotrypsin cleavage site at Phe-242 would, thus, imply a minimum peptide length of residues 216-242, of similar size to that obtained by tryptic cleavage.
Thus, the results with two different proteases suggest that two tubulin sequence regions are involved in colchicine binding and that these can form covalent bonds with the drug by direct photolabeling. As has been discussed (9, 10), the chemistry of the photoreaction is not well understood, and we could, thus, not identify the photodegradation product; because of low yields, we were unable to identify the specific (missing) amino acid(s) that reacted with the excited state colchicine. Why the two peptides were so closely associated through a variety of manipulations was not clear. Initially it was thought that these two regions might have become crosslinked by colchicine as a result of the irradiation (10), but HPLC separation on a C18 column permitted us to identify the tryptic peptide fragment 214-241 separated from the N-terminal peptide (although the peak was not clean). Isoelectric-focusing gels over the pH range of 4.0-8.0 of the isolated 4.6-kDa fragment showed a single band with an isoelectric point of 7.3.
To resolve the problem of the association of fragment 1-46 and 214-241 and to determine whether both were labeled, we used limited proteolysis with trypsin to isolate and purify peptides that could then be definitively identified as N-terminal or C-terminal in immunoblots (Fig. 3) . Under the conditions used (trypsin/,B-tubulin, 1:100/Mes assembly buffer, pH 6.9, 0°C, 8-10 min), 6 of 11 Coomassie-stained bands (labeled I-VI in Fig. 3, lane 1) were identified in immunoblots by use of monoclonal antibodies directed against the N-or C-terminal portions of 3-tubulin. The N-terminal epitope, not identified by the supplier, resides somewhere between 4 and 16 kDa from the N terminus, whereas the C-terminal antibody (N357) has its epitope at residues 416-430. As shown in Fig. 3, lanes 2 and 3, intact 3-tubulin stained with both antibodies, as expected. Bands II, IV, and V stained only with the anti-C-terminal antibody, whereas bands I, III, and VI stained only with the anti-Nterminal antibody. Membranes probed with N-terminal antibody (lane 2) were reprobed with C-terminal antibody (lane 4) to prove that bands II and III were distinct and to rule out contamination of band III with band II because they were very near each other. The results clearly show that bands I and III are N-terminal and that band II is of C-terminal origin.
Good labeling was obtained in bands I, II, III, and VI (see legend to Fig. 3) . Because the 35-kDa C-terminal band II and the 16-kDa N-terminal band VI together constituted approximately the mass (-50 kDa) of the intact ,B-tubulin and because sequence analysis showed that the isolated 16-kDa peptide (VI) started at methionine, residue 1, the limited tryptic cleavage probably occurred at Lys-154 or Arg-156. Moreover, formation of these two covalently labeled, and presumably contiguous, peptides (16-kDa N-terminal plus 35-kDa C-terminal, =50-kDa) can be considered supporting evidence for two separate colchicine-binding regions in 1tu-bulin.
Extensive hydrolysis of the N-terminal peptide (Fig. 4 Upper) yielded a labeled -4-kDa peptide from the 16-kDa peptide, the sequence analysis of which yielded residues 1-20 of f-tubulin. [This fragment no longer stained with the anti-N-terminal monoclonal antibody, suggesting that the epitope lies beyond residue =46 but before residue 154 (based on gel molecular masses).] The Inset shows the Coomassiestained gel that was analyzed for radioactivity. An identical gel was transferred to an Immobilon-P membrane, and the highly labeled band (arrow) was used for sequence analysis. The labeled =4-kDa peptide derived from the 35-kDa C-terminal peptide yielded a highly labeled fragment 214-241 (Fig.  4 Lower). As for the N-terminal peptide above, the Inset shows the Coomassie-stained gel that was analyzed for radioactivity. An identical gel was transferred to an Immobilon-P membrane, and the highly labeled band (arrow) was used for sequence analysis. Thus, it is clear that (i) the two peptides are separate and are not covalently linked by the direct photolabeling procedure and (ii) colchicine is cova- (20) , stimulates GTPase activity (21) , induces small CD changes in the protein (22) , increases the affinity between the a and (3 monomers (23, 24) , and influences crosslinking by bifunctional sulfhydryl reagents (7, 25, 26) . The locus on ,3tubulin where colchicine produces these effects had not, however, been established and required direct binding-site identification. The present findings are consistent with a model in which two peptides far removed from each other in the primary sequence of,3-tubulin-namely, residues 1-46 and 214-241-are regions constituting a portion of the colchicine-binding site. A diagram of the relationship of these two sequence regions to each other and to other functions of these regions is depicted in Fig. 5 . The fact that the A and C rings of colchicine each have a binding locus and that there is a stoichiometry of one colchicine bound per native tubulin dimer (1, 2) then requires that, to contribute significantly to the binding, the two regions must not be more than= 1 A apart (the maximum span of colchicine, as judged by Dreyding models), but they could be closer, depending on the orientation of colchicine between the two chains. In attempting to localize the -SH groups crosslinked by bifunctional reagents (25, 26) , two crosslinks were identified: C239 to C354 and C12 to C201 or C211. With the crosslinker used [N, N'-ethylenebis(iodoacetamide)], the maximum span is =9 A; spacers larger than two carbons decreased crosslinking efficiency. These crosslinked cysteines are in regions near both colchicine-binding regions (Fig. 5) , and it is interesting that both crosslinking reactions were modulated by colchicine: C239-C354 formation was blocked by colchicine, and C12-C201 or -C211 was stimulated by colchicine. Another reagent, 2,4-dichlorobenzylthiocyanate, which under defined conditions reacts at C239, is also inhibited from reacting by colchicine (27) .
These colchicine-binding regions are also involved with GTP binding and, thus, represent active regulatory domains of 3-tubulin. Recently it was shown that C12 of f-tubulin forms an adduct with GTP (28) . Thus, although long-range effects cannot be ruled out, the effect of colchicine on both C12 and C239 crosslinks is consistent with our assignment of the colchicine-binding domains to peptides 1-46 and 214-241. Other sequences of ,B-tubulin may also be involved in colchicine binding (Figs. 2 and 3 ). Whether these bands are precursor peptides or provide other binding surfaces remains to be determined. Moreover, the region of a-tubulin that is near enough to the colchicine-binding site on ,B-tubulin to become labeled under mild denaturing conditions (6, 9, 10) remains to be identified. Nonetheless, our findings identify two regions of 3-tubulin that are important structural elements of the colchicine-binding site. This result requires that the two regions, although far apart in the primary sequence, are within 11 A of each other in native tubulin.
